reports
EQS-News: plenum AG zieht positive Bilanz für das Geschäftsjahr 2024 u...
EQS-News: plenum AG / Schlagwort(e): Zwischenbericht plenum AG zieht positive Bilanz für das Geschäftsjahr 2024 und blickt mit Zuversicht auf 2025 03.04.2025 / 13:40 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die plenum AG kann trotz herausfordernder Marktbedingungen auf ein insgesamt erfolgreiches Geschäftsjahr 2024 zurückblicken. Umsatz und Ergebnis konnten stabil gehalten bzw. leicht gesteigert werden. Wesentliche Säulen des Geschäfts waren Projekte in der Energie- und Versicherungswirtschaft mit Fokus auf IT-Transformation u...
Jeffs’ Brands Finalizes Android Version of AI-Based Pest Control App- ...
Jeffs’ Brands Finalizes Android Version of AI-Based Pest Control App- Ready for Google Play Submission Tel Aviv, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, announced today, that further to its previously announcement on March 27, 2025, its wholly-owned subsidiary, Fort Products Limited. (“Fort”), has completed the internal testing and fine tuning stage for its Android version of its AI-powered pest control mobile app. Fort is now preparing to su...
Sensirion Holding AG: 2 directors
Two Directors at Sensirion Holding AG sold 2,850 shares at between 68.865CHF and 68.932CHF. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ...
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting MELBOURNE, Australia and SAN FRANCISCO, April 03, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an oral presentation and a poster presentation related to Alterity’s clinical programs in Multiple System Atrophy (MSA) will be delivered at the American Academy...
Iceland Seafood International hf: Bond Exchange Offer Result
Iceland Seafood International hf: Bond Exchange Offer Result In relation with ISI’s bond auction in the series ICESEA 28 10 yesterday, holders of the series ICESEA 25 06 were offered to sell holdings in the series at a predetermined clean price of 100,8715 in exchange for subscriptions made in the offering.The exchange offer results in ISI buying back ISK 2.880 m nominal in the series ICESEA 25 06.Settlement is expected to take place on April 7th 2025.The offering is managed by Arion Bank Capital Markets. Further Information: Iceland Seafood International hf.Ægir Páll Friðbertsson CEO, ...
Man Group PLC : Form 8.3 - Spirent Communications plc
Man Group PLC : Form 8.3 - Spirent Communications plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant sec...
FTI Consulting to Release First Quarter 2025 Results and Host Conferen...
FTI Consulting to Release First Quarter 2025 Results and Host Conference Call WASHINGTON, April 03, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the first quarter ended March 31, 2025 before the New York market opens on Thursday, April 24, 2025. A conference call will be held to discuss these financial results on Thursday, April 24, 2025, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company's . A ...
Suyog Telematics Ltd: 1 director
A director at Suyog Telematics Ltd bought 329,884 shares at 570.000INR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skil...
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Thrive Skilled Pediatric Care ("Thrive SPC"). The transaction is expected to close in the second fiscal quarter of 2025, subject to customary regulatory approvals. Thrive SPC is one of the largest independent providers of pedi...
Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2...
Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient has been dosed in MAGNITUDE-2, a global, pivotal Phase 3 trial of nexiguran ziclumeran (nex-z) for the treatment of hereditary ATTR amyloid...
MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction o...
MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews Each Betty’s Caramelt Away Chew Uses Rich, Buttery Caramel, To Create Moments of Mellow NORWOOD, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious caramel chews: Betty’s Caramelt Away. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: M...
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 T...
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) Topline Phase 2 clinical data expected in the first half 2025 NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing new oral combination medicines, today announced that the Company has completed Phase 2 patient enrollment in the global Phase 2/3 RePOSA study of IHL-42X for the treatment of Obstructiv...
Sonim Technologies, Inc. Special Committee Confirms Receipt of Unsolic...
San Diego, California--(Newsfile Corp. - April 3, 2025) - Sonim Technologies, Inc. (NASDAQ: SONM) today confirmed that it has received an unsolicited non-binding proposal from Orbic North America, LLC ("Orbic") to acquire all outstanding shares of Sonim Technologies for $4.00 per share in cash.Sonim, through a previously established Special Committee of the Board composed of independent directors, is carefully reviewing and evaluating the proposal in consultation with its legal and financial advisors. The Special Committee is committed to conducting a thorough and deliberate assessment of the ...
Serve Robotics Saddles Up for Autonomous Delivery in Dallas-Fort Worth...
Serve Robotics Saddles Up for Autonomous Delivery in Dallas-Fort Worth Via Uber Eats DALLAS, April 03, 2025 (GLOBE NEWSWIRE) -- (“Serve”) (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today announced the launch of its service in the Dallas-Fort Worth metro area. This strategic expansion, in continued partnership with Uber Eats—the delivery platform of Uber Technologies Inc. (NYSE: UBER)— represents a major milestone in Serve’s plan to deploy 2,000 AI-powered delivery robots across the U.S. by the end of 2025. Serve robots have begun operating in the Uptown neighbor...
Top Kingwin Ltd’s Subsidiary Tiancheng Chuangxin Technology Announces ...
Top Kingwin Ltd’s Subsidiary Tiancheng Chuangxin Technology Announces its Plan to Launch Desktop Robot 1.0 – Redefining the Smart Office Companion GuangZhou, China, April 03, 2025 (GLOBE NEWSWIRE) -- Top Kingwin Ltd (NASDAQ: WAI) is pleased to announce that its subsidiary, Shenzhen Tiancheng Chuangxin Technology Co., Ltd. (“Chuangxin Tech”), has announced its plan of releasing a self-developed Desktop Robot 1.0. This innovative product will integrate artificial intelligence (“AI”) with emotional interaction, aiming to deliver a smarter and more empathetic office and lifestyle experience....
Jayud Global Logistics Issues Statement Regarding Market Activity
Jayud Global Logistics Issues Statement Regarding Market Activity SHENZHEN, China, April 03, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen specializing in cross-border logistics, issued the following statement in response to the market activity on April 1 and April 2: While it is the Company's practice not to comment on any stock movement, we must caution investors and all other persons to rely solely on statements and filings with the United States Securities and Ex...
ProVen Growth and Income VCT plc: Issue of Equity
ProVen Growth and Income VCT plc: Issue of Equity ProVen Growth and Income VCT plc (the “Company”)Issue of Equity 3 April 2025 The Directors of ProVen Growth and Income VCT plc announce an allotment on 3 April 2025 of ordinary shares of 1.6187p each ("Ordinary Shares") pursuant to the offer for subscription that opened on 6 November 2024. 2,878,630 Ordinary Shares were allotted at an average price of 52.82p, based on the latest net asset value of 50.45p, being the net asset value per Ordinary Share as at 30 November 2024 adjusted for the dividend of 1.25p paid on 17 January 2025. Appli...
EQS-News: vbw Pressemitteilung zum „Roundtable Automobilindustrie“ mit...
Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung zum „Roundtable Automobilindustrie“ mit EU-Kommissar Tzitzikostas: Eine starke europäische Automobilwirtschaft durch Dialog mit der EU 03.04.2025 / 13:17 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Eine starke europäische Automobilwirtschaft durch Dialog mit der EUBrossardt: „Technologieoffenheit stärken, um im globalen Wettbewerb zu bestehen“ (München, 03.04.2025). „Die europäische Fahrzeug...
Man Group PLC : Form 8.3 - International Distribution Services plc
Man Group PLC : Form 8.3 - International Distribution Services plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose...
ProVen VCT plc: Issue of Equity
ProVen VCT plc: Issue of Equity ProVen VCT plc Issue of equity3 April 2025 The Directors of ProVen VCT plc announce an allotment on 3 April 2025 of ordinary shares of 10p each ("Ordinary Shares") pursuant to the offer for subscription that opened on 6 November 2024. 2,708,172 Ordinary Shares were allotted at an average price of 65.34p, based on the latest net asset value of 62.5p, being the net asset value per Ordinary Share as at 30 November 2024 adjusted for the dividend of 1.5p paid on 17 January 2025. Application for the shares to be admitted to the Official List of the Financial Co...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.